Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study

Background Identifying the early-stage colon adenocarcinoma (ECA) patients who have lower risk cancer vs. the higher risk cancer could improve disease prognosis. Our study aimed to explore whether the glandular morphological features determined by computational pathology could identify high risk can...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of translational medicine 2020-03, Vol.18 (1), p.129-129, Article 129
Hauptverfasser: Ji, Meng-Yao, Yuan, Lei, Lu, Shi-Min, Gao, Meng-Ting, Zeng, Zhi, Zhan, Na, Ding, Yi-Juan, Liu, Zheng-Ru, Huang, Ping-Xiao, Lu, Cheng, Dong, Wei-Guo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 129
container_issue 1
container_start_page 129
container_title Journal of translational medicine
container_volume 18
creator Ji, Meng-Yao
Yuan, Lei
Lu, Shi-Min
Gao, Meng-Ting
Zeng, Zhi
Zhan, Na
Ding, Yi-Juan
Liu, Zheng-Ru
Huang, Ping-Xiao
Lu, Cheng
Dong, Wei-Guo
description Background Identifying the early-stage colon adenocarcinoma (ECA) patients who have lower risk cancer vs. the higher risk cancer could improve disease prognosis. Our study aimed to explore whether the glandular morphological features determined by computational pathology could identify high risk cancer in ECA via H&E images digitally. Methods 532 ECA patients retrospectively from 2 independent data centers, as well as 113 from The Cancer Genome Atlas (TCGA), were enrolled in this study. Four tissue microarrays (TMAs) were constructed across ECA hematoxylin and eosin (H&E) stained slides. 797 quantitative glandular morphometric features were extracted and 5 most prognostic features were identified using minimum redundancy maximum relevance to construct an image classifier. The image classifier was evaluated on D2/D3 = 223, D4 = 46, D5 = 113. The expression of Ki67 and serum CEA levels were scored on D3, aiming to explore the correlations between image classifier and immunohistochemistry data and serum CEA levels. The roles of clinicopathological data and ECAHBC were evaluated by univariate and multivariate analyses for prognostic value. Results The image classifier could predict ECA recurrence (accuracy of 88.1%). ECA histomorphometric-based image classifier (ECAHBC) was an independent prognostic factor for poorer disease-specific survival [DSS, (HR = 9.65, 95% CI 2.15-43.12, P = 0.003)]. Significant correlations were observed between ECAHBC-positive patients and positivity of Ki67 labeling index (Ki67Li) and serum CEA. Conclusion Glandular orientation and shape could predict the high risk cancer in ECA and contribute to precision oncology. Computational pathology is emerging as a viable and objective means of identifying predictive biomarkers for cancer patients.
doi_str_mv 10.1186/s12967-020-02297-w
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2379063795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A618737970</galeid><doaj_id>oai_doaj_org_article_43ac82cadd724a669f55924df372d21d</doaj_id><sourcerecordid>A618737970</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-64a4f8f87d1040937232c4be73358a79a8c3b23ca06941e42ee248c9697facc73</originalsourceid><addsrcrecordid>eNqNks1u1DAUhSMEomXgBVggS2yQUIr_EscsKlUjKJUqsYG1dce-mXGVxIOddDQvwvPiacrQIhbI8o9uvnOsG5-ieM3oGWNN_SExrmtVUk7z5FqVuyfFKZNKl1Wj6qcPzifFi5RuKOWykvp5cSI4U02t6Wnx87KDwU0dRBKix2GE0YeB5BpJG9gicThi7P2Ajqz2xIZ-O80MdGQL4yZ0YX2oT50j3mUD3-4JrNcRU_K3SMapD5G0eSLE7kB22d9CtH4IPXwkQMbotx2WNosxkjRObv-yeNZCl_DV_b4ovn_-9G35pbz-enm1vLgubVWLsawlyLZpG-UYlVQLxQW3coVKiKoBpaGxYsWFBVpryVByRC4bq2utWrBWiUVxNfu6ADdmG30PcW8CeHNXCHFtII7edmikANtwC84pLqGudVtVmkvX5lsdZy57nc9e22nVozu0E6F7ZPr4y-A3Zh1ujaJKUdpkg3f3BjH8mDCNpvfJYpdfCMOUDBdKaS2r3N2iePsXehOmmN_kjtK0zkv1h1pDbsAPbcj32oOpuahZozKkaKbO_kHl4bD3NgzY-lx_JOCzwMaQUsT22COj5pBMMyfT5GSau2SaXRa9efh3jpLfUczA-xnY4Sq0yeYwWjxilNKKM8oEy6e8LYrm_-mlnyO7DNMwil_cJgIA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2379063795</pqid></control><display><type>article</type><title>Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Web of Science - Science Citation Index Expanded - 2020&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><creator>Ji, Meng-Yao ; Yuan, Lei ; Lu, Shi-Min ; Gao, Meng-Ting ; Zeng, Zhi ; Zhan, Na ; Ding, Yi-Juan ; Liu, Zheng-Ru ; Huang, Ping-Xiao ; Lu, Cheng ; Dong, Wei-Guo</creator><creatorcontrib>Ji, Meng-Yao ; Yuan, Lei ; Lu, Shi-Min ; Gao, Meng-Ting ; Zeng, Zhi ; Zhan, Na ; Ding, Yi-Juan ; Liu, Zheng-Ru ; Huang, Ping-Xiao ; Lu, Cheng ; Dong, Wei-Guo</creatorcontrib><description>Background Identifying the early-stage colon adenocarcinoma (ECA) patients who have lower risk cancer vs. the higher risk cancer could improve disease prognosis. Our study aimed to explore whether the glandular morphological features determined by computational pathology could identify high risk cancer in ECA via H&amp;E images digitally. Methods 532 ECA patients retrospectively from 2 independent data centers, as well as 113 from The Cancer Genome Atlas (TCGA), were enrolled in this study. Four tissue microarrays (TMAs) were constructed across ECA hematoxylin and eosin (H&amp;E) stained slides. 797 quantitative glandular morphometric features were extracted and 5 most prognostic features were identified using minimum redundancy maximum relevance to construct an image classifier. The image classifier was evaluated on D2/D3 = 223, D4 = 46, D5 = 113. The expression of Ki67 and serum CEA levels were scored on D3, aiming to explore the correlations between image classifier and immunohistochemistry data and serum CEA levels. The roles of clinicopathological data and ECAHBC were evaluated by univariate and multivariate analyses for prognostic value. Results The image classifier could predict ECA recurrence (accuracy of 88.1%). ECA histomorphometric-based image classifier (ECAHBC) was an independent prognostic factor for poorer disease-specific survival [DSS, (HR = 9.65, 95% CI 2.15-43.12, P = 0.003)]. Significant correlations were observed between ECAHBC-positive patients and positivity of Ki67 labeling index (Ki67Li) and serum CEA. Conclusion Glandular orientation and shape could predict the high risk cancer in ECA and contribute to precision oncology. Computational pathology is emerging as a viable and objective means of identifying predictive biomarkers for cancer patients.</description><identifier>ISSN: 1479-5876</identifier><identifier>EISSN: 1479-5876</identifier><identifier>DOI: 10.1186/s12967-020-02297-w</identifier><identifier>PMID: 32178690</identifier><language>eng</language><publisher>LONDON: Springer Nature</publisher><subject>Adenocarcinoma ; Biological markers ; Biomarkers, Tumor ; Cancer genetics ; Cancer research ; Carcinoma ; Chemotherapy ; Clinical pathology ; Colon ; Colon adenocarcinoma ; Colon cancer ; Colorectal cancer ; Computer applications ; Data centers ; Diagnosis ; Diseases ; Genomes ; Genomics ; Gland heterogeneity ; Glands ; Histochemistry ; Humans ; Immunohistochemistry ; Life Sciences &amp; Biomedicine ; Machine learning ; Medical examination ; Medical prognosis ; Medical research ; Medicine, Research &amp; Experimental ; Morphology ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Oncology ; Pathology ; Precision Medicine ; Prognosis ; Quantitative histopathology images ; Research &amp; Experimental Medicine ; Retrospective Studies ; Science &amp; Technology ; Surgery ; Survival analysis ; Technology application ; Tumors</subject><ispartof>Journal of translational medicine, 2020-03, Vol.18 (1), p.129-129, Article 129</ispartof><rights>COPYRIGHT 2020 BioMed Central Ltd.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>3</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000521013100001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c563t-64a4f8f87d1040937232c4be73358a79a8c3b23ca06941e42ee248c9697facc73</citedby><cites>FETCH-LOGICAL-c563t-64a4f8f87d1040937232c4be73358a79a8c3b23ca06941e42ee248c9697facc73</cites><orcidid>0000-0002-7651-3924</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077008/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077008/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,28253,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32178690$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ji, Meng-Yao</creatorcontrib><creatorcontrib>Yuan, Lei</creatorcontrib><creatorcontrib>Lu, Shi-Min</creatorcontrib><creatorcontrib>Gao, Meng-Ting</creatorcontrib><creatorcontrib>Zeng, Zhi</creatorcontrib><creatorcontrib>Zhan, Na</creatorcontrib><creatorcontrib>Ding, Yi-Juan</creatorcontrib><creatorcontrib>Liu, Zheng-Ru</creatorcontrib><creatorcontrib>Huang, Ping-Xiao</creatorcontrib><creatorcontrib>Lu, Cheng</creatorcontrib><creatorcontrib>Dong, Wei-Guo</creatorcontrib><title>Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study</title><title>Journal of translational medicine</title><addtitle>J TRANSL MED</addtitle><addtitle>J Transl Med</addtitle><description>Background Identifying the early-stage colon adenocarcinoma (ECA) patients who have lower risk cancer vs. the higher risk cancer could improve disease prognosis. Our study aimed to explore whether the glandular morphological features determined by computational pathology could identify high risk cancer in ECA via H&amp;E images digitally. Methods 532 ECA patients retrospectively from 2 independent data centers, as well as 113 from The Cancer Genome Atlas (TCGA), were enrolled in this study. Four tissue microarrays (TMAs) were constructed across ECA hematoxylin and eosin (H&amp;E) stained slides. 797 quantitative glandular morphometric features were extracted and 5 most prognostic features were identified using minimum redundancy maximum relevance to construct an image classifier. The image classifier was evaluated on D2/D3 = 223, D4 = 46, D5 = 113. The expression of Ki67 and serum CEA levels were scored on D3, aiming to explore the correlations between image classifier and immunohistochemistry data and serum CEA levels. The roles of clinicopathological data and ECAHBC were evaluated by univariate and multivariate analyses for prognostic value. Results The image classifier could predict ECA recurrence (accuracy of 88.1%). ECA histomorphometric-based image classifier (ECAHBC) was an independent prognostic factor for poorer disease-specific survival [DSS, (HR = 9.65, 95% CI 2.15-43.12, P = 0.003)]. Significant correlations were observed between ECAHBC-positive patients and positivity of Ki67 labeling index (Ki67Li) and serum CEA. Conclusion Glandular orientation and shape could predict the high risk cancer in ECA and contribute to precision oncology. Computational pathology is emerging as a viable and objective means of identifying predictive biomarkers for cancer patients.</description><subject>Adenocarcinoma</subject><subject>Biological markers</subject><subject>Biomarkers, Tumor</subject><subject>Cancer genetics</subject><subject>Cancer research</subject><subject>Carcinoma</subject><subject>Chemotherapy</subject><subject>Clinical pathology</subject><subject>Colon</subject><subject>Colon adenocarcinoma</subject><subject>Colon cancer</subject><subject>Colorectal cancer</subject><subject>Computer applications</subject><subject>Data centers</subject><subject>Diagnosis</subject><subject>Diseases</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Gland heterogeneity</subject><subject>Glands</subject><subject>Histochemistry</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Machine learning</subject><subject>Medical examination</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine, Research &amp; Experimental</subject><subject>Morphology</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasm Staging</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Precision Medicine</subject><subject>Prognosis</subject><subject>Quantitative histopathology images</subject><subject>Research &amp; Experimental Medicine</subject><subject>Retrospective Studies</subject><subject>Science &amp; Technology</subject><subject>Surgery</subject><subject>Survival analysis</subject><subject>Technology application</subject><subject>Tumors</subject><issn>1479-5876</issn><issn>1479-5876</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNqNks1u1DAUhSMEomXgBVggS2yQUIr_EscsKlUjKJUqsYG1dce-mXGVxIOddDQvwvPiacrQIhbI8o9uvnOsG5-ieM3oGWNN_SExrmtVUk7z5FqVuyfFKZNKl1Wj6qcPzifFi5RuKOWykvp5cSI4U02t6Wnx87KDwU0dRBKix2GE0YeB5BpJG9gicThi7P2Ajqz2xIZ-O80MdGQL4yZ0YX2oT50j3mUD3-4JrNcRU_K3SMapD5G0eSLE7kB22d9CtH4IPXwkQMbotx2WNosxkjRObv-yeNZCl_DV_b4ovn_-9G35pbz-enm1vLgubVWLsawlyLZpG-UYlVQLxQW3coVKiKoBpaGxYsWFBVpryVByRC4bq2utWrBWiUVxNfu6ADdmG30PcW8CeHNXCHFtII7edmikANtwC84pLqGudVtVmkvX5lsdZy57nc9e22nVozu0E6F7ZPr4y-A3Zh1ujaJKUdpkg3f3BjH8mDCNpvfJYpdfCMOUDBdKaS2r3N2iePsXehOmmN_kjtK0zkv1h1pDbsAPbcj32oOpuahZozKkaKbO_kHl4bD3NgzY-lx_JOCzwMaQUsT22COj5pBMMyfT5GSau2SaXRa9efh3jpLfUczA-xnY4Sq0yeYwWjxilNKKM8oEy6e8LYrm_-mlnyO7DNMwil_cJgIA</recordid><startdate>20200316</startdate><enddate>20200316</enddate><creator>Ji, Meng-Yao</creator><creator>Yuan, Lei</creator><creator>Lu, Shi-Min</creator><creator>Gao, Meng-Ting</creator><creator>Zeng, Zhi</creator><creator>Zhan, Na</creator><creator>Ding, Yi-Juan</creator><creator>Liu, Zheng-Ru</creator><creator>Huang, Ping-Xiao</creator><creator>Lu, Cheng</creator><creator>Dong, Wei-Guo</creator><general>Springer Nature</general><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7651-3924</orcidid></search><sort><creationdate>20200316</creationdate><title>Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study</title><author>Ji, Meng-Yao ; Yuan, Lei ; Lu, Shi-Min ; Gao, Meng-Ting ; Zeng, Zhi ; Zhan, Na ; Ding, Yi-Juan ; Liu, Zheng-Ru ; Huang, Ping-Xiao ; Lu, Cheng ; Dong, Wei-Guo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-64a4f8f87d1040937232c4be73358a79a8c3b23ca06941e42ee248c9697facc73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma</topic><topic>Biological markers</topic><topic>Biomarkers, Tumor</topic><topic>Cancer genetics</topic><topic>Cancer research</topic><topic>Carcinoma</topic><topic>Chemotherapy</topic><topic>Clinical pathology</topic><topic>Colon</topic><topic>Colon adenocarcinoma</topic><topic>Colon cancer</topic><topic>Colorectal cancer</topic><topic>Computer applications</topic><topic>Data centers</topic><topic>Diagnosis</topic><topic>Diseases</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Gland heterogeneity</topic><topic>Glands</topic><topic>Histochemistry</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Machine learning</topic><topic>Medical examination</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine, Research &amp; Experimental</topic><topic>Morphology</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasm Staging</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Precision Medicine</topic><topic>Prognosis</topic><topic>Quantitative histopathology images</topic><topic>Research &amp; Experimental Medicine</topic><topic>Retrospective Studies</topic><topic>Science &amp; Technology</topic><topic>Surgery</topic><topic>Survival analysis</topic><topic>Technology application</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ji, Meng-Yao</creatorcontrib><creatorcontrib>Yuan, Lei</creatorcontrib><creatorcontrib>Lu, Shi-Min</creatorcontrib><creatorcontrib>Gao, Meng-Ting</creatorcontrib><creatorcontrib>Zeng, Zhi</creatorcontrib><creatorcontrib>Zhan, Na</creatorcontrib><creatorcontrib>Ding, Yi-Juan</creatorcontrib><creatorcontrib>Liu, Zheng-Ru</creatorcontrib><creatorcontrib>Huang, Ping-Xiao</creatorcontrib><creatorcontrib>Lu, Cheng</creatorcontrib><creatorcontrib>Dong, Wei-Guo</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of translational medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ji, Meng-Yao</au><au>Yuan, Lei</au><au>Lu, Shi-Min</au><au>Gao, Meng-Ting</au><au>Zeng, Zhi</au><au>Zhan, Na</au><au>Ding, Yi-Juan</au><au>Liu, Zheng-Ru</au><au>Huang, Ping-Xiao</au><au>Lu, Cheng</au><au>Dong, Wei-Guo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study</atitle><jtitle>Journal of translational medicine</jtitle><stitle>J TRANSL MED</stitle><addtitle>J Transl Med</addtitle><date>2020-03-16</date><risdate>2020</risdate><volume>18</volume><issue>1</issue><spage>129</spage><epage>129</epage><pages>129-129</pages><artnum>129</artnum><issn>1479-5876</issn><eissn>1479-5876</eissn><abstract>Background Identifying the early-stage colon adenocarcinoma (ECA) patients who have lower risk cancer vs. the higher risk cancer could improve disease prognosis. Our study aimed to explore whether the glandular morphological features determined by computational pathology could identify high risk cancer in ECA via H&amp;E images digitally. Methods 532 ECA patients retrospectively from 2 independent data centers, as well as 113 from The Cancer Genome Atlas (TCGA), were enrolled in this study. Four tissue microarrays (TMAs) were constructed across ECA hematoxylin and eosin (H&amp;E) stained slides. 797 quantitative glandular morphometric features were extracted and 5 most prognostic features were identified using minimum redundancy maximum relevance to construct an image classifier. The image classifier was evaluated on D2/D3 = 223, D4 = 46, D5 = 113. The expression of Ki67 and serum CEA levels were scored on D3, aiming to explore the correlations between image classifier and immunohistochemistry data and serum CEA levels. The roles of clinicopathological data and ECAHBC were evaluated by univariate and multivariate analyses for prognostic value. Results The image classifier could predict ECA recurrence (accuracy of 88.1%). ECA histomorphometric-based image classifier (ECAHBC) was an independent prognostic factor for poorer disease-specific survival [DSS, (HR = 9.65, 95% CI 2.15-43.12, P = 0.003)]. Significant correlations were observed between ECAHBC-positive patients and positivity of Ki67 labeling index (Ki67Li) and serum CEA. Conclusion Glandular orientation and shape could predict the high risk cancer in ECA and contribute to precision oncology. Computational pathology is emerging as a viable and objective means of identifying predictive biomarkers for cancer patients.</abstract><cop>LONDON</cop><pub>Springer Nature</pub><pmid>32178690</pmid><doi>10.1186/s12967-020-02297-w</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-7651-3924</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1479-5876
ispartof Journal of translational medicine, 2020-03, Vol.18 (1), p.129-129, Article 129
issn 1479-5876
1479-5876
language eng
recordid cdi_proquest_journals_2379063795
source MEDLINE; DOAJ Directory of Open Access Journals; SpringerNature Journals; PubMed Central Open Access; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central; Springer Nature OA/Free Journals
subjects Adenocarcinoma
Biological markers
Biomarkers, Tumor
Cancer genetics
Cancer research
Carcinoma
Chemotherapy
Clinical pathology
Colon
Colon adenocarcinoma
Colon cancer
Colorectal cancer
Computer applications
Data centers
Diagnosis
Diseases
Genomes
Genomics
Gland heterogeneity
Glands
Histochemistry
Humans
Immunohistochemistry
Life Sciences & Biomedicine
Machine learning
Medical examination
Medical prognosis
Medical research
Medicine, Research & Experimental
Morphology
Neoplasm Recurrence, Local
Neoplasm Staging
Oncology
Pathology
Precision Medicine
Prognosis
Quantitative histopathology images
Research & Experimental Medicine
Retrospective Studies
Science & Technology
Surgery
Survival analysis
Technology application
Tumors
title Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T04%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glandular%20orientation%20and%20shape%20determined%20by%20computational%20pathology%20could%20identify%20aggressive%20tumor%20for%20early%20colon%20carcinoma:%20a%20triple-center%20study&rft.jtitle=Journal%20of%20translational%20medicine&rft.au=Ji,%20Meng-Yao&rft.date=2020-03-16&rft.volume=18&rft.issue=1&rft.spage=129&rft.epage=129&rft.pages=129-129&rft.artnum=129&rft.issn=1479-5876&rft.eissn=1479-5876&rft_id=info:doi/10.1186/s12967-020-02297-w&rft_dat=%3Cgale_proqu%3EA618737970%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2379063795&rft_id=info:pmid/32178690&rft_galeid=A618737970&rft_doaj_id=oai_doaj_org_article_43ac82cadd724a669f55924df372d21d&rfr_iscdi=true